Table 2 Changes in patient history and drug use
From: Oculogyric crisis symptoms related to risperidone treatment: a case report
Treat environment | Time | Symptoms | Complementary check | Diagnosis | Main Medication | With or without OGC |
|---|---|---|---|---|---|---|
Hospitalization (First time) | April 15, 2021-September 2021 | Verbal Hallucinations, inhibition of thought, delusion of reference, inattention, anxiety, no self-awareness | CSF routine, biochemistry, and autoimmune encephalitis were unremarkable, and video EEG and MRI of the cranial brain were normal | Acute schizophrenia-like psychotic disorder | Aripiprazole 30 mg/d Risperidone 2 mg/d | without |
outpatient service | September 2021-March 2022 | Positive symptoms in remission, no self-awareness | Self-discontinuation of medication | without | ||
Hospitalization (Second time) | March 17,2022- August 2022 | Verbal hallucinations, delusions of victimization, feelings of being watched and controlled, delusions of physical influence, no self-awareness | video EEG and MRI of the cranial brain were normal | schizophrenia | Aripiprazole 20 mg/d Risperidone 6 mg/d | With OGC(Episodes of upwards rolling eyes, gazing, closed eyes are seen on both sides of the upper eyelid muscles, involuntary trembling, cannot control themselves, feeling pain and irritability, seizure process is clear consciousness, no limbic spasms, urinary and faeces incontinence and other manifestations, lasting a few minutes to half an hour, and self-relieving) |
outpatient service | September 2022-April 2023 | Intermittent medication | ||||
Hospitalization (Third time) | April 13, 2023—April 15, 2023 | Verbal Hallucinations, inhibition of thought, no self-awareness | Risperidone 6 mg/d | |||
April 16, 2023-April 19, 2023 | Risperidone 4 mg/d | |||||
hospitalization + outpatient service | April 20, 2023, to present | Symptoms in remission, she was able to go to school | clozapine 125 mg/d | without |